🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effects of a Dietary Supplement in Women With Late Perimenopause or Early Postmenopause

RecruitingNAAges 42 Years - 60 YearsFemaleUniversity of Alicante
NCT07863973 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will evaluate the effects of a plant extract-based dietary supplement on menopausal symptoms and health indicators in women with late perimenopause or early postmenopause. Approximately 120 women aged 42 to 60 years will be randomly assigned to receive either the dietary supplement or a placebo daily for 12 weeks. Neither the participants nor the research team will know the assigned treatment during the study. Assessments will include the frequency and severity of hot flashes and night sweats, menopausal symptoms, quality of life, sleep quality, emotional well-being, body composition, and selected laboratory parameters.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Women aged 42 to 60 years. * Late perimenopause or early postmenopause. * Amenorrhea for at least 3 months and no more than 10 years since menopause. * At least five moderate or severe hot flashes per day during the screening period. * Body mass index of 35 kg/m² or less. * Written informed consent. Exclusion Criteria: * Serious uncontrolled diseases. * Treatments that may interfere with the assessment of the primary outcome measures. * Known allergy or intolerance to any component of the study product. * Concurrent participation in another clinical trial. * Any circumstance that, in the investigator's judgment, would hinder compliance with the study protocol.
💊

What it tests

  • Plant Extract-Based Dietary Supplement
  • Placebo
📍

Where

1 site
European Institute Of Exercise and Health
Elche, Spain
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy